New Pediatric Consensus Transforms Clinical Management of Childhood Nocturnal Enuresis and Bed-wetting

A groundbreaking consensus published in the World Journal of Pediatrics is set to modernize the treatment of nocturnal enuresis (NE) in children. By establishing 18 evidence-based recommendations, the new framework provides a roadmap for clinicians to move beyond trial-and-error approaches toward highly standardized, individualized care. The updated guidance addresses critical gaps in diagnosis and management, ensuring that pediatric patients receive care tailored to their specific clinical phenotypes.

A major shift in this protocol is the lowering of the diagnostic threshold to at least one involuntary nighttime void per month for three months in children aged five and older. This change facilitates earlier clinical intervention, which is vital for mitigating the negative impact of persistent bed-wetting on a child’s self-esteem and social functioning. Furthermore, the consensus mandates a clear distinction between monosymptomatic NE and non-monosymptomatic NE to guide better treatment outcomes.

The framework emphasizes the use of voiding diaries as a diagnostic cornerstone, allowing for phenotype-driven therapies like desmopressin or alarm systems. By prioritizing the management of daytime symptoms and comorbidities, such as constipation, this new standard of care aims to improve long-term prognosis. These recommendations serve as a vital resource for primary care providers to identify when specialist intervention is necessary, ultimately fostering better coordination across the healthcare system.